Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study

Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study

Background: Restless Legs Syndrome (RLS) is a common movement disorder with an estimated prevalence of up to 12%. Previous small studies with onabotulinumtoxin A (OnaA) for RLS have shown inconsistent results. Methods: Twenty-four patients with an International RLS score (IRLS) of >11 (modera...

Full description

Bibliographic Details
Main Authors: Shivam Om Mittal, Duarte Machado, Diana Richardson, Divyanshu Dubey, Bahman Jabbari
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Toxins
Subjects:
incobotulinumtoxin A
restless legs syndrome
botulinum toxin
clinical trial
sleep
movement disorder
Online Access:http://www.mdpi.com/2072-6651/10/10/401

Internet

http://www.mdpi.com/2072-6651/10/10/401

Similar Items